Monte Rosa Therapeutics, Inc. (GLUE) Balance Sheet
As of 2026-06-30 (10-Q), Monte Rosa Therapeutics, Inc. (GLUE) reported total assets of $691.2M, total liabilities of $203.9M and shareholders' equity of $487.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $90.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
GLUEMonte Rosa Therapeutics, Inc.Follow GLUE — free
—
Price chart with a free account
- Market cap
- 924.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 346.1 | 54.9 | 128.1 | 224.3 | 129.9 | 90.1 | |
| Current assets | 348.7 | 275.9 | 236.2 | 377.4 | 393.2 | 631.4 | |
| Total assets | 366.3 | 342.4 | 303.8 | 438.7 | 448.7 | 691.2 | |
| Current liabilities | 16.6 | 25.6 | 46.6 | 156.9 | 64.2 | 59.7 | |
| Total liabilities | 18.8 | 71.0 | 124.5 | 215.8 | 215.6 | 203.9 | |
| Shareholders' equity | 347.5 | 271.4 | 179.3 | 222.9 | 233.1 | 487.3 |
USD millions · SEC XBRL
Monte Rosa Therapeutics, Inc. — questions
- How much cash does Monte Rosa Therapeutics, Inc. have?
- $90.1M in cash and cash equivalents as of 2026-06-30.
- What are Monte Rosa Therapeutics, Inc.'s total assets?
- $691.2M as of 2026-06-30.
- What is Monte Rosa Therapeutics, Inc.'s shareholders' equity?
- $487.3M as of 2026-06-30.
Every figure on this page comes from Monte Rosa Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.